Dr. Fiellin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
789 Howard Ave
Ynhh
New Haven, CT 06519Phone+1 203-688-2471Fax+1 203-688-4516
Education & Training
- Yale-New Haven Medical CenterResidency, Internal Medicine, 1991 - 1994
- Emory University School of MedicineClass of 1991
Certifications & Licensure
- CT State Medical License 1994 - 2025
- American Board of Preventive Medicine Addiction Medicine
Clinical Trials
- Buprenorphine and Integrated HIV Care Evaluation Start of enrollment: 2005 Aug 01
- Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence Start of enrollment: 2008 Jul 01
- Testing a Primary Care Model for the Treatment of Opioid Dependence Using Long-acting Injectable Naltrexone (Vivitrol). Start of enrollment: 2011 May 01
- Join now to see all
Publications & Presentations
PubMed
- 267 citationsEffects of Marijuana Smoking on Pulmonary Function and Respiratory Complications: A Systematic ReviewJeanette M. Tetrault, Kristina Crothers, Brent A. Moore, Reena Mehra, John Concato
Archives of Internal Medicine. 2007-02-12 - 70 citationsThe epidemiology of substance use disorders in US Veterans: A systematic review and analysis of assessment methods.Chiao Wen Lan, David A. Fiellin, Declan T. Barry, Kendall J. Bryant, Adam J. Gordon
The American Journal on Addictions. 2016-01-01 - 147 citationsRisk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected menAmy C. Justice, Kathleen A. McGinnis, Janet P. Tate, R. Scott Braithwaite, Kendall J. Bryant
Drug and Alcohol Dependence. 2016-04-01
Journal Articles
- Racial Disparities in Discontinuation of Long-Term Opioid Therapy Following Illicit Drug Use Among Black and White PatientsDavid A Fiellin, William C Becker, Drug and Alcohol Dependence
- Efficacy of Extended-Release Naltrexone on HIV-Related and Drinking Outcomes Among HIV-Positive Patients: A Randomized-Controlled TrialStephen R Holt, Michael Virata, David A Fiellin, E Jennifer Edelman, Lynn E Fiellin, AIDS and Behavior
- Level of Alcohol Use Associated with HIV Care Continuum Targets in a National U.S. Sample of Persons Living with HIV Receiving HealthcareE Jennifer Edelman, Derek D Satre, David A Fiellin, Adam J Gordon, Katharine A Bradley, AIDS and Behavior
- Join now to see all
Authored Content
- Toward Better Stewardship: Gaining Control over Controlled SubstancesMay 2018
- Toward Better Stewardship: Gaining Control over Controlled SubstancesMay 2018
Press Mentions
- Why Do so Few U.S. Psych Hospitals Use Medications for Opioid Use Disorder?November 14th, 2024
- More Doctors Can Now Prescribe a Key Opioid Treatment. Will It Help?March 3rd, 2023
- Amid Fentanyl Crisis, First-of-Its-Kind Study to Evaluate Expanded Methadone AccessFebruary 24th, 2023
- Join now to see all
Grant Support
- Integrated Stepped Care For Unhealthy Alcohol Use In HIVNational Institute On Alcohol Abuse And Alcoholism2011
- Models Of Sbirt For Opioid Dependent Patients In The Emergency DepartmentNational Institute On Drug Abuse2008–2011
- Buprenorphine Maintenance Vs. Detoxification In Prescription Opioid DependenceNational Institute On Drug Abuse2007–2011
- Counseling For Primary Care Office-Based BuprenorphineNational Institute On Drug Abuse2005–2009
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: